Health Action International
loading
  • ANITA FREHE: I worry that future breast cancer patients won't be able to access the same medicines that I did.

  • PROF. DR. ERNST KUIPERS: I want to see many new medicines come onto the market, but rising prices are making them unaffordable.

  • WHY ARE MEDICINE PRICES SO HIGH? Take a look at how the pharmaceutical industry is rapidly increasing prices for new medicines.

Sign up to get the latest updates

WE DEMAND ACTION ON MEDICINE PRICES

Every year, the prices of new medicines in the Netherlands get higher and higher.

But as prices skyrocket and our insurance premiums rise, the pharmaceutical industry continues to ignore calls for greater public scrutiny of their price increases. Whether it’s secrecy in the prices being paid for medicines in different countries, secrecy in revealing the true research and development (R&D) costs, including how much of it was paid for by taxpayers, we think it’s about time for us to know the whole picture.

Consider this—in 2003, we spent €270 million on cancer medicines. In 2013, it was €733 million. Between 2011 and 2014, prices for some cancer drugs rose by 80%. Today, it's not uncommon for our hospitals to pay €54,000 for a breast cancer treatment or €52,000 for a twelve-week course of medication for Hepatitis C.

All in all, it costs €1.7 billion for Dutch hospitals to provide just these high-priced medicines to patients—and that was in 2014.

It’s no wonder the Dutch Society of Hospitals has warned that these costs are unsustainable, telling the government that if nothing changes, hospitals will no longer be able to guarantee access to expensive medicines. That means hospitals could soon have to refuse a patient access to a medicine because they simply can’t afford it.

We can’t let this happen.

In an open and democratic society, the price we pay for medicines to care for our sick should be public information. Companies should also be open about their true R&D costs, including how much of it was paid for by taxpayers. With doctors, patients, insurers and hospitals all warning that prices for new medicines are unsustainable, the time has come to restore power to taxpayers by demanding an open and transparent industry.

WILL YOU JOIN THE CAMPAIGN FOR FAIR MEDICINE PRICES? 


TAKE ACTION NOW


A CAMPAIGN BY:

HAI-color-web.pngwww.haiweb.org

flag_yellow_low.jpg

This campaign for fair medicine prices received funding under an operating grant from the European Union’s Health Programme (2014–2020).

 

SUPPORTED BY 

logo_red.png logo-kwf-600x316.jpg logo_diabetesfonds_kleur.jpg IVM_logo_engels.jpg
Aidsfonds  KWF Kankerbestrijding Diabetes Fonds   Dutch Institute for Rational Use of Medicine
 logo_Wemos_-pay-off_RGB_1_.jpg nvnlogo_kleiner.jpg longfonds_logo20132.jpg logo.png
Wemos 

Nierpatiënten Vereniging Nederland, NVN

Longfonds Nierstichting
borstkankervereniging_nederland_logo.JPG  FM_logo_descriptor_web.jpeg    
 Borstkankervereniging Nederland Fair Medicine